Recent Finacing
Recent Raise
SeaBeLife is a French biotech developing first-in-class small-molecule drugs that simultaneously inhibit necroptosis and ferroptosis to treat dry age-related macular degeneration and severe acute hepatitis.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
